CLINICAL_TRIALS
trial_result
· 2010-12-17
Clinical Trial Update: Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma [Phase 2]
Summary
Phase 2 trial of a multi-antigen therapeutic vaccine for metastatic melanoma was terminated, with results posted in December 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Melanoma, Cancer | Phase 2 | Status: TERMINATED | Results posted: 2010-12-17